Z4D — Medi Lifestyle Income Statement
0.000.00%
- SG$1.15m
- SG$1.30m
- MYR1.84m
Annual income statement for Medi Lifestyle, fiscal year end - December 31st, MYR millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.623 | 1.4 | 2.4 | 1.94 | 1.84 |
Cost of Revenue | |||||
Gross Profit | 0.085 | 0.492 | 0.093 | 0.154 | -0.212 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5 | 14.1 | 6.35 | 8.47 | 6.69 |
Operating Profit | -4.38 | -12.7 | -3.95 | -6.53 | -4.85 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -4.38 | -13.6 | -4.33 | -7.19 | -5.33 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.38 | -13.7 | -4.3 | -7.19 | -5.34 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2.76 | -23.7 | -4.3 | -7.19 | -5.34 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.76 | -23.7 | -4.3 | -7.19 | -5.34 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.09 | -0.172 | -0.088 | -0.08 | -0.036 |